购物车
- 全部删除
- 您的购物车当前为空
Icotinib Hydrochloride (BPI-2009H) 是一种口服的基于喹唑啉的表皮生长因子受体 (EGFR) 抑制剂,IC50值为5 nM,具有潜在的抗肿瘤活性。
Icotinib Hydrochloride (BPI-2009H) 是一种口服的基于喹唑啉的表皮生长因子受体 (EGFR) 抑制剂,IC50值为5 nM,具有潜在的抗肿瘤活性。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
1 mg | ¥ 542 | 现货 | |
5 mg | ¥ 1,320 | 现货 | |
10 mg | ¥ 1,990 | 现货 | |
25 mg | ¥ 3,430 | 现货 | |
50 mg | ¥ 4,970 | 现货 | |
100 mg | ¥ 6,880 | 现货 | |
200 mg | ¥ 9,270 | 现货 | |
1 mL x 10 mM (in DMSO) | ¥ 1,790 | 现货 |
产品描述 | Icotinib Hydrochloride (BPI-2009H) is the hydrochloride salt form of icotinib, an orally available quinazoline-based inhibitor of EGFR, with potential antineoplastic activity. Icotinib selectively inhibits the wild-type and several mutated forms of EGFR tyrosine kinase. This may lead to an inhibition of EGFR-mediated signal transduction and may inhibit cancer cell proliferation. EGFR, a receptor tyrosine kinase, has been upregulated in a variety of cancer cell types. |
靶点活性 | EGFR:5 nM |
别名 | 盐酸埃克替尼, 埃克替尼盐酸盐, BPI-2009H |
分子量 | 427.88 |
分子式 | C22H22ClN3O4 |
CAS No. | 1204313-51-8 |
Smiles | Cl.C#Cc1cccc(Nc2ncnc3cc4OCCOCCOCCOc4cc23)c1 |
密度 | no data available |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||
溶解度信息 | DMSO: 12 mg/mL (28.04 mM) | |||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||
DMSO
|
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.
评论内容